“Making monoclonal antibodies broadly accessible to communities most at risk of HIV/AIDS – What would it take?’’
A webinar in partnership with IAVI.
A webinar in partnership with IAVI.
The Global HIV Vaccine Enterprise at the International AIDS Society and IAVI are pleased to invite you to join a webinar to discuss challenges and opportunities on the Access to future monoclonal antibodies for HIV prevention:
“Making monoclonal antibodies broadly accessible to communities most at risk of HIV/AIDS – What would it take?’’
The Webinar features an introduction from Mark Feinberg, CEO and President of IAVI, followed by perspectives of a renowned panel of experts on R&D, manufacturing, access, policy and regulation, and a 30-minute audience Q&A.
The webinar is aimed at researchers, civil society, pharmaceutical and biotechnology companies, funders, regulators, policy makers, and other members of the global health community. The meeting will contribute to a better understanding of the huge potential of antibodies for HIV prevention, and the proposed actions to overcome the obstacles on the way to affordable global access to these tools.
Date: Monday, 23 November 2020
Time: 10:00-11:30 (EST)
Use this tool to see the time of the webinar at your location.
We look forward to you joining us!
Access to Antibodies, a Global Call to Action
As highlighted in this report published recently by IAVI and Wellcome, the potential of monoclonal antibodies (mAbs) to treat and prevent infectious and neglected diseases is enormous. Yet, with 8 mAb-based products targeting infectious diseases licensed to date, and a rapidly expanding pipeline, most of the world’s population is unlikely to have access to them, unless the global health community takes urgent action to address this inequity.
Established in 2003, the Global HIV Vaccine Enterprise (the Enterprise) became a programme of IAS – the International AIDS Society – in 2018. The Enterprise unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of – and future access to – an HIV vaccine.
IAS – the International AIDS Society
Avenue de France 23
CH-1202 Geneva
Switzerland
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy policy